Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

DARE Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 12, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Dare Bioscience Inc (DARE)

Based on 10 analysts giving stock ratings to Dare Bioscience Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
20
Buy
70
Hold
10
Sell
0
Strong Sell
0
Dare Bioscience Inc

Dare Bioscience Inc. Stock Analysis DARE

United States Health Care Nano Cap Report:
Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. The company is headquartered in San Diego, California and currently employs 21 full-time employees. The company went IPO on 2014-04-10. The firm's programs target unmet needs in women's health, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Its product includes XACIATO (clindamycin phosphate) vaginal gel 2%. XACIATO is a single-dose prescription medication for the treatment of bacterial vaginosis in females 12 years of age and older. Its other product candidates include Ovaprene, Sildenafil Cream, and DARE-HRT1. Ovaprene is an investigational, hormone-free, monthly intravaginal contraceptive. Sildenafil Cream is a novel cream formulation of sildenafil for the treatment of female sexual arousal disorder; and DARE-HRT1 is an intravaginal ring designed to deliver a combination of menopausal hormone therapy, bio-identical 17b-estradiol and progesterone together, continuously over a 28-day period for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes.
Read More

Dare Bioscience Inc (DARE) Chart

Key Statistics of Dare Bioscience Inc (DARE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.02$2.11

Today's Open

$2.02

Volume

66.13K

P/E Ratio (TTM)

-

52 Week Range

$1.27$9.19

Market Cap

36.10M

Avg. Volume

193.04K

Dividend Yield

-

Financial Metrics & Statements of Dare Bioscience Inc (DARE)

FAQ's for Dare Bioscience Inc (DARE)

  • According to Musaffa’s Shariah screening methodology, Dare Bioscience Inc (DARE) is currently classified as NOT HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Dare Bioscience Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Dare Bioscience Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Dare Bioscience Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Dare Bioscience Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Dare Bioscience Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.